FLUOXETINE Side Effects

7027024-2 | Muscular Weakness, Myopathy, Urticaria
on Sep 17, 2010 Female patient from , 87 years of age, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: muscular weakness, myopathy, urticaria. Fluoxetine dosage: 20mg-daily-oral. During the same period patient was treated with BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ).

7023572-X | Muscular Weakness, Myopathy, Urticaria
Patient was taking Fluoxetine (View Usage). Patient had the following side effects: muscular weakness, myopathy, urticaria on Sep 17, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 87 years of age, was diagnosed with depression (What is depression?), hypertension, anxiety (What is anxiety?) and. Fluoxetine dosage: . During the same period patient was treated with BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ).

7023571-8 | Muscular Weakness, Myopathy, Urticaria
Adverse event was reported on Sep 17, 2010 by a Female patient taking Fluoxetine (View Usage) (Dosage: ) was diagnosed with depression (What is depression?), hypertension, anxiety (What is anxiety?) and. Location: UNITED KINGDOM , 87 years of age, After Fluoxetine was administered, patient had the following side effects: muscular weakness, myopathy, urticaria. During the same period patient was treated with BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ).

7022235-4 | Muscular Weakness, Myopathy, Urticaria
on Sep 17, 2010 Female patient from UNITED KINGDOM , 87 years of age, was diagnosed with depression (What is depression?), hypertension, anxiety (What is anxiety?) and was treated with Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: muscular weakness, myopathy, urticaria. Fluoxetine dosage: 20 Mg, Daily (1/d). During the same period patient was treated with BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ).


7022027-6 | Myopathy, Urticaria
on Sep 17, 2010 Female patient from , 87 years of age, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). Patient had the following side effects: myopathy, urticaria. Fluoxetine dosage: 20 Mg;qd;po. During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

7021495-3 | Chest Pain, Dyspepsia, Influenza Like Illness, Psychotic Disorder
Patient was taking Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: chest pain (What is chest pain?), dyspepsia, influenza like illness, psychotic disorder (What is psychotic disorder?) on Sep 15, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 165.0 lb, was diagnosed with depression (What is depression?) and. Fluoxetine dosage: (40 Mg Bid Oral).

7017562-0 | Faeces Discoloured, Libido Disorder
Adverse event was reported on Jul 14, 2010 by a Male patient taking Fluoxetine (View Usage) (Dosage: ) . Location: UNITED STATES , 60 years of age, Patient experienced the following unwanted or unexpected effects: faeces discoloured, libido disorder. During the same period patient was treated with REMERON (View Remeron Review and Remeron Label ).

7017559-0 | Myoclonic Epilepsy
on Sep 15, 2009 Male patient from UNITED STATES , 58 years of age, weighting 180.0 lb, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?), depression (What is depression?) and was treated with Fluoxetine (View Usage). Patient had the following side effects: myoclonic epilepsy. Fluoxetine dosage: .

7016047-5 | Muscular Weakness, Myopathy, Urticaria
on Sep 17, 2010 Female patient from UNITED KINGDOM , 87 years of age, was diagnosed with depression (What is depression?), hypertension, anxiety (What is anxiety?) and was treated with Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: muscular weakness, myopathy, urticaria. Fluoxetine dosage: 20 Mg, Qid. During the same period patient was treated with BENDROFLUMETHIAZIDE (2.5 Mg) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DIAZEPAM (2 Mg) (View Diazepam Review and Diazepam Label ), PERINDOPRIL (8 Mg) (View Perindopril Review and Perindopril Label ).

7014168-4 | Electrocardiogram Qt Interval, Intentional Overdose, Leukocytosis, Suicide Attempt
Patient was taking Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt interval, intentional overdose, leukocytosis, suicide attempt on Sep 13, 2010 from NORWAY Additional patient health information: Female patient , 42 years of age, was diagnosed with suicide attempt and. Fluoxetine dosage: 800 Mg, Unk. During the same period patient was treated with ZOPICLONE (View Zopiclone Review and Zopiclone Label ), SERTINDOLE (1792 Mg, Unk) (View Sertindole Review and Sertindole Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

7008580-7 | Humerus Fracture, Pathological Fracture, Radius Fracture, Spinal Fracture, Ulna Fracture
Adverse event was reported on Sep 08, 2010 by a Female patient taking Fluoxetine (View Usage) (Dosage: 20 Mg, Daily) was diagnosed with depression (What is depression?) and. Location: UNITED KINGDOM , 33 years of age, Patient had the following side effects: humerus fracture, pathological fracture, radius fracture, spinal fracture, ulna fracture. Patient was hospitalized.

7007139-5 | Product Substitution Issue
on Sep 07, 2010 Female patient from UNITED STATES , 13 years of age, was treated with Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: product substitution issue. Fluoxetine dosage: (20 Mg Qd Oral), (20 Mg Qd Oral), (30 Mg Qd Oral), (20 Mg Qd Oral).

6972979-5 | Convulsion, Hyponatraemia
on Aug 27, 2010 Male patient from UNITED KINGDOM , 49 years of age, weighting 90.39 lb, was diagnosed with neuralgia and was treated with Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hyponatraemia. Fluoxetine dosage: . Patient was hospitalized.

6971991-X | Completed Suicide, Intentional Overdose
Patient was taking Fluoxetine (View Usage). Patient had the following side effects: completed suicide, intentional overdose on Aug 24, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 25 years of age, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and. Fluoxetine dosage: . During the same period patient was treated with TEMAZEPAM (View Temazepam Review and Temazepam Label ), ALCOHOL (View Alcohol Review and Alcohol Label ), CIPRALEX (View Cipralex Review and Cipralex Label ).

6971219-0 | Completed Suicide, Intentional Overdose
Adverse event was reported on Aug 24, 2010 by a Female patient taking Fluoxetine (View Usage) (Dosage: ) was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and. Location: UNITED KINGDOM , 25 years of age, After Fluoxetine was administered, patient had the following side effects: completed suicide, intentional overdose. During the same period patient was treated with TEMAZEPAM (View Temazepam Review and Temazepam Label ), ALCOHOL (View Alcohol Review and Alcohol Label ), CIPRALEX (View Cipralex Review and Cipralex Label ).

6970417-X | Completed Suicide
on Aug 24, 2010 Female patient from DENMARK , 25 years of age, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Fluoxetine dosage: Po. During the same period patient was treated with IBUPROFEN (Po) (View Ibuprofen Review and Ibuprofen Label ), OXAZEPAM CAPSULES USP, 30 MG (PUREPAC) (OXAZEPAM) (Po) (View Oxazepam Capsules Usp, 30 Mg (purepac) (oxazepam) Review and Oxazepam Capsules Usp, 30 Mg (purepac) (oxazepam) Label ), TEMAZEPAM (Po) (View Temazepam Review and Temazepam Label ), CIPRALEX (NO PREF. NAME) (220 Mg; Po) (View Cipralex (no Pref. Name) Review and Cipralex (no Pref. Name) Label ), ALCOHOL (ETHANOL) (Po) (View Alcohol (ethanol) Review and Alcohol (ethanol) Label ), PROZAC (View Prozac Review and Prozac Label ), NORTRIPTYLINE HCL (Po) (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ).

6969878-1 | Electrocardiogram Qt Interval, Intentional Overdose, Leukocytosis, Suicide Attempt
on Aug 25, 2010 Female patient from NORWAY , 42 years of age, was diagnosed with suicide attempt and was treated with Fluoxetine (View Usage). Patient had the following side effects: electrocardiogram qt interval, intentional overdose, leukocytosis, suicide attempt. Fluoxetine dosage: 800 Mg, Unk. During the same period patient was treated with ZOPICLONE (View Zopiclone Review and Zopiclone Label ), SERTINDOLE (1792 Mg, Unk) (View Sertindole Review and Sertindole Label ), LITHIUM (View Lithium Review and Lithium Label ). Patient was hospitalized.

6969084-0 | Completed Suicide, Intentional Overdose
Patient was taking Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: completed suicide, intentional overdose on Aug 24, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 25 years of age, was diagnosed with anxiety (What is anxiety?), depression (What is depression?) and. Fluoxetine dosage: . During the same period patient was treated with TEMAZEPAM (View Temazepam Review and Temazepam Label ), ALCOHOL (View Alcohol Review and Alcohol Label ), CIPRALEX (View Cipralex Review and Cipralex Label ).

6967286-0 | Abasia, Cerebellar Infarction, Cerebellar Ischaemia, Chills, Cognitive Disorder, Dysarthria, Gait Disturbance, Mydriasis
Adverse event was reported on Aug 26, 2010 by a Male patient taking Fluoxetine (View Usage) (Dosage: 20 Mg;qd) . Location: SPAIN , 74 years of age, Patient experienced the following unwanted or unexpected effects: abasia, cerebellar infarction, cerebellar ischaemia, chills, cognitive disorder, dysarthria, gait disturbance, mydriasis. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (20 Mg;qd) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), REBOXETINE (REBOXETINE) (4 Mg; Qd;) (View Reboxetine (reboxetine) Review and Reboxetine (reboxetine) Label ), CIPROFLOXACIN (500 Mg; Bid;) (View Ciprofloxacin Review and Ciprofloxacin Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), SULPIRIDE (View Sulpiride Review and Sulpiride Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6959417-3 | Anger, Anxiety, Depression, Dizziness, Fear, Product Substitution Issue
on Aug 31, 2010 Female patient from UNITED STATES , weighting 158.0 lb, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). Patient had the following side effects: anger, anxiety (What is anxiety?), depression (What is depression?), dizziness (What is dizziness?), fear, product substitution issue. Fluoxetine dosage: 2-20mg 2/day Twice Oral.

6959415-X | Agitation, Crying, Depression
on Aug 31, 2010 Female patient from UNITED STATES , weighting 230.0 lb, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: agitation, crying, depression (What is depression?). Fluoxetine dosage: .

6942859-X | Alcohol Interaction, Intentional Overdose, Stupor, Suicide Attempt
Patient was taking Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol interaction, intentional overdose, stupor, suicide attempt on Aug 13, 2010 from SWITZERLAND Additional patient health information: Female patient , 33 years of age, . Fluoxetine dosage: 100 Mg, Other. During the same period patient was treated with VALIUM (20 D/f, Other) (View Valium Review and Valium Label ), ETHANOL (0.5 Liter, Other) (View Ethanol Review and Ethanol Label ). Patient was hospitalized.

6930764-4 | Nausea, Product Substitution Issue
Adverse event was reported on Aug 18, 2010 by a Female patient taking Fluoxetine (View Usage) (Dosage: One Capsule Daily Po) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , weighting 190.0 lb, Patient had the following side effects: nausea (What is nausea?), product substitution issue.

6923715-X | Loss Of Consciousness, Paraesthesia
on Aug 03, 2010 Female patient from AUSTRALIA , 47 years of age, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: loss of consciousness, paraesthesia. Fluoxetine dosage: 20 Mg, Daily (1/d). During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ).

6913680-3 | Depression Suicidal, Dyspepsia
on Jul 20, 2010 Female patient from , 61 years of age, weighting 154.0 lb, was treated with Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: depression suicidal, dyspepsia. Fluoxetine dosage: . During the same period patient was treated with CHAMPIX (1mg, Bid, Oral) (View Champix Review and Champix Label ).

6907950-2 | Serotonin Syndrome
Patient was taking Fluoxetine (View Usage). Patient had the following side effects: serotonin syndrome on Jul 22, 2010 from AUSTRALIA Additional patient health information: Female patient , 42 years of age, . Fluoxetine dosage: . During the same period patient was treated with MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), MORPHINE (View Morphine Review and Morphine Label ), CODEINE (View Codeine Review and Codeine Label ).

6907945-9 | Serotonin Syndrome
Adverse event was reported on Jul 22, 2010 by a Male patient taking Fluoxetine (View Usage) (Dosage: ) . Location: AUSTRALIA , 50 years of age, After Fluoxetine was administered, patient had the following side effects: serotonin syndrome. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6907360-8 | Epistaxis, Eye Pain, Lymphoma, Malignant Neoplasm Progression, Musculoskeletal Stiffness, Nausea
on Jul 20, 2010 Female patient from UNITED KINGDOM , 55 years of age, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, eye pain, lymphoma (What is lymphoma?), malignant neoplasm progression, musculoskeletal stiffness, nausea (What is nausea?). Fluoxetine dosage: 20 Mg, Oral. During the same period patient was treated with KALMS (KALMS /00796301/) (View Kalms (kalms /00796301/) Review and Kalms (kalms /00796301/) Label ).

6905734-2 | Depression Suicidal, Dyspepsia
on Jul 21, 2010 Female patient from UNITED KINGDOM , 61 years of age, weighting 154.0 lb, was treated with Fluoxetine (View Usage). Patient had the following side effects: depression suicidal, dyspepsia. Fluoxetine dosage: . During the same period patient was treated with CHAMPIX (View Champix Review and Champix Label ).

6905731-7 | Depression Suicidal, Dyspepsia
Patient was taking Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: depression suicidal, dyspepsia on Jul 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 61 years of age, weighting 154.0 lb, . Fluoxetine dosage: . During the same period patient was treated with CHAMPIX (View Champix Review and Champix Label ).

6905693-2 | Serotonin Syndrome
Adverse event was reported on Jul 21, 2010 by a Female patient taking Fluoxetine (View Usage) (Dosage: ) . Location: AUSTRALIA , 42 years of age, Patient experienced the following unwanted or unexpected effects: serotonin syndrome. During the same period patient was treated with MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), MORPHINE (View Morphine Review and Morphine Label ), CODEINE (View Codeine Review and Codeine Label ).

6905688-9 | Serotonin Syndrome
on Jul 21, 2010 Female patient from AUSTRALIA , 42 years of age, was treated with Fluoxetine (View Usage). Patient had the following side effects: serotonin syndrome. Fluoxetine dosage: . During the same period patient was treated with MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), MORPHINE (View Morphine Review and Morphine Label ), CODEINE (View Codeine Review and Codeine Label ).

6905687-7 | Serotonin Syndrome
on Jul 21, 2010 Female patient from AUSTRALIA , 42 years of age, was treated with Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: serotonin syndrome. Fluoxetine dosage: . During the same period patient was treated with MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), MORPHINE (View Morphine Review and Morphine Label ), CODEINE (View Codeine Review and Codeine Label ).

6905614-2 | Serotonin Syndrome
Patient was taking Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: serotonin syndrome on Jul 21, 2010 from AUSTRALIA Additional patient health information: Male patient , 26 years of age, . Fluoxetine dosage: . During the same period patient was treated with TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6900789-3 | Depression Suicidal, Dyspepsia
Adverse event was reported on Jul 20, 2010 by a Female patient taking Fluoxetine (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 61 years of age, Patient had the following side effects: depression suicidal, dyspepsia. During the same period patient was treated with CHAMPIX (NO PREF. NAME) (1 Mg;bid;po) (View Champix (no Pref. Name) Review and Champix (no Pref. Name) Label ), CON MEDS (View Con Meds Review and Con Meds Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ).

6900611-5 | Epistaxis, Eye Pain, Lymphoma, Malignant Neoplasm Progression, Musculoskeletal Stiffness, Nausea
on Jul 20, 2010 Female patient from , 55 years of age, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: epistaxis, eye pain, lymphoma (What is lymphoma?), malignant neoplasm progression, musculoskeletal stiffness, nausea (What is nausea?). Fluoxetine dosage: 20mg, Oral. During the same period patient was treated with KALMS (View Kalms Review and Kalms Label ).

6900608-5 | Epistaxis, Eye Pain, Lymphoma, Malignant Neoplasm Progression, Musculoskeletal Stiffness, Nausea
on Jul 20, 2010 Female patient from European Union , 55 years of age, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: epistaxis, eye pain, lymphoma (What is lymphoma?), malignant neoplasm progression, musculoskeletal stiffness, nausea (What is nausea?). Fluoxetine dosage: 20 Mg, Po. During the same period patient was treated with KALMS (View Kalms Review and Kalms Label ).

6900178-1 | Epistaxis, Eye Pain, Malignant Neoplasm Progression, Musculoskeletal Stiffness, Nausea
Patient was taking Fluoxetine (View Usage). Patient had the following side effects: epistaxis, eye pain, malignant neoplasm progression, musculoskeletal stiffness, nausea (What is nausea?) on Jul 20, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 55 years of age, was diagnosed with depression (What is depression?) and. Fluoxetine dosage: 20 Mg, Unk. During the same period patient was treated with KALMS /00796301/ (View Kalms /00796301/ Review and Kalms /00796301/ Label ).

6899634-4 | Depression Suicidal, Dyspepsia
Adverse event was reported on Jul 20, 2010 by a Female patient taking Fluoxetine (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 61 years of age, weighting 154.0 lb, After Fluoxetine was administered, patient had the following side effects: depression suicidal, dyspepsia. During the same period patient was treated with CHAMPIX (1 Mg, Bid) (View Champix Review and Champix Label ).

6897342-7 | Blood Pressure Systolic Increased, Spasmodic Dysphonia
on Jul 14, 2010 Female patient from AUSTRALIA , 35 years of age, was treated with Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure systolic increased, spasmodic dysphonia. Fluoxetine dosage: 60 Mg, 80 Mg. During the same period patient was treated with ACUPHASE (ZUCLOPENTHIXOL) (100 Mg, Intramuscular) (View Acuphase (zuclopenthixol) Review and Acuphase (zuclopenthixol) Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ). Patient was hospitalized.

6894421-5 | Completed Suicide, Psychotic Disorder, Thinking Abnormal
on Jul 13, 2010 Female patient from UNITED KINGDOM , 64 years of age, weighting 143.3 lb, was diagnosed with depression (What is depression?), pain (What is pain?) and was treated with Fluoxetine (View Usage). Patient had the following side effects: completed suicide, psychotic disorder (What is psychotic disorder?), thinking abnormal. Fluoxetine dosage: 40 Mg, Qd, Oral. During the same period patient was treated with TRAMADOL HCL (50 Mg, Qid, Oral) (View Tramadol Hcl Review and Tramadol Hcl Label ), ALENDRONATE (ALENDRONATE ACID) (View Alendronate (alendronate Acid) Review and Alendronate (alendronate Acid) Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6894185-5 | Blood Pressure Systolic Increased, Spasmodic Dysphonia
Patient was taking Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: blood pressure systolic increased, spasmodic dysphonia on Jul 14, 2010 from AUSTRALIA Additional patient health information: Female patient , 35 years of age, . Fluoxetine dosage: 60 Mg, Unk. During the same period patient was treated with ACUPHASE (100 Mg, Unk) (View Acuphase Review and Acuphase Label ), QUETIAPINE (1500 Mg, Unk) (View Quetiapine Review and Quetiapine Label ), NITRAZEPAM (375 Mg, Unk) (View Nitrazepam Review and Nitrazepam Label ). Patient was hospitalized.

6894013-8 | Completed Suicide, Thinking Abnormal
Adverse event was reported on Jul 13, 2010 by a Female patient taking Fluoxetine (View Usage) (Dosage: 40 Mg, Qd) was diagnosed with depression (What is depression?), pain (What is pain?), osteoporosis prophylaxis, blood folate decreased, psychotic disorder (What is psychotic disorder?), prophylaxis against gastrointestinal ulcer, alveolitis allergic and. Location: UNITED KINGDOM , 64 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: completed suicide, thinking abnormal. During the same period patient was treated with TRAMADOL HYDROCHLORIDE (50 Mg, Qid) (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), ALENDRONATE SODIUM (70 Mg, 1/week) (View Alendronate Sodium Review and Alendronate Sodium Label ), FOLIC ACID (5 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), OLANZAPINE (20 Mg, Qd) (View Olanzapine Review and Olanzapine Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (30 Mg, Unk) (View Prednisolone Review and Prednisolone Label ).

6888126-4 | Retinal Detachment
on Jul 09, 2010 Male patient from UNITED KINGDOM , 54 years of age, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). Patient had the following side effects: retinal detachment. Fluoxetine dosage: 20 Mg, 2 In 1 D, Oral.

6883117-1 | Retinal Detachment
on Jul 12, 2010 Male patient from , 54 years of age, was diagnosed with depression (What is depression?) and was treated with Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: retinal detachment. Fluoxetine dosage: 20mg, Bid, Oral.

6881946-1 | Retinal Detachment
Patient was taking Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: retinal detachment on Jul 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 54 years of age, was diagnosed with depression (What is depression?) and. Fluoxetine dosage: .

6881945-X | Retinal Detachment
Adverse event was reported on Jul 12, 2010 by a Male patient taking Fluoxetine (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: UNITED KINGDOM , 54 years of age, Patient had the following side effects: retinal detachment.

6879472-9 | Depression Suicidal, Dyspepsia
on Jul 20, 2010 Female patient from UNITED KINGDOM , 61 years of age, weighting 154.0 lb, was treated with Fluoxetine (View Usage). After Fluoxetine was administered, patient had the following side effects: depression suicidal, dyspepsia. Fluoxetine dosage: . During the same period patient was treated with VARENICLINE TARTRATE (1 Mg, Bid) (View Varenicline Tartrate Review and Varenicline Tartrate Label ).

6877087-X | Addison's Disease, Convulsion, Hypoxia, Pneumonia Viral
on Jul 27, 2010 Female patient from UNITED STATES , weighting 194.0 lb, was diagnosed with depression (What is depression?), pneumonia (What is pneumonia?) and was treated with Fluoxetine (View Usage). Patient experienced the following unwanted or unexpected effects: addison's disease (What is addison's disease?), convulsion, hypoxia, pneumonia viral. Fluoxetine dosage: 40mg Daily Po. During the same period patient was treated with LINEZOLID (600mg Q 12 Hours Iv) (View Linezolid Review and Linezolid Label ).

6876492-5 | Completed Suicide, Thinking Abnormal
Patient was taking Fluoxetine (View Usage). Patient had the following side effects: completed suicide, thinking abnormal on Jul 13, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 64 years of age, weighting 143.3 lb, was diagnosed with depression (What is depression?), pain (What is pain?), osteoporosis prophylaxis, blood folate decreased, prophylaxis against gastrointestinal ulcer, alveolitis allergic and. Fluoxetine dosage: 40 Mg, Daily (1/d). During the same period patient was treated with OLANZAPINE (20 Mg, Daily (1/d)) (View Olanzapine Review and Olanzapine Label ), TRAMADOL HYDROCHLORIDE (50 Mg, 4/d) (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), ALENDRONATE SODIUM (70 Mg, Weekly (1/w)) (View Alendronate Sodium Review and Alendronate Sodium Label ), FOLIC ACID (5 Mg, Daily (1/d)) (View Folic Acid Review and Folic Acid Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (30 Mg, Unk) (View Prednisolone Review and Prednisolone Label ).